Figure 1.
Figure 1. Mutational complexity and prognosis in intermediate-risk AML. (A-B) Circos plots of AML patients with cytogenetically defined intermediate-risk disease with intermediate mutational risk (A) or unfavorable mutational risk (B). (C) Survival curves for FLT3-ITD–positive and negative intermediate-risk disease (used with permission from Patel et al21).

Mutational complexity and prognosis in intermediate-risk AML. (A-B) Circos plots of AML patients with cytogenetically defined intermediate-risk disease with intermediate mutational risk (A) or unfavorable mutational risk (B). (C) Survival curves for FLT3-ITD–positive and negative intermediate-risk disease (used with permission from Patel et al21 ).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal